NFKB1 and colitis: In a mouse model of colitis evoked by DSS, Cheng et al. have found that ghrelin inhibits the development of colitis and prevents the breakdown of intestinal barrier function, and these effects seem to be related to the ghrelin-induced inhibition of NF-κB activation [228].